1,583,154 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Acquired by Wellington Management Group LLP

Wellington Management Group LLP bought a new stake in Upstream Bio, Inc. (NASDAQ:UPB) in the 4th quarter, HoldingsChannel reports. The fund bought 1,583,154 shares of the company’s stock, valued at approximately $25,632,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. US Bancorp DE acquired a new position in shares of Upstream Bio during the fourth quarter valued at about $27,000. Corebridge Financial Inc. purchased a new stake in Upstream Bio during the 4th quarter worth approximately $142,000. Rhumbline Advisers acquired a new position in Upstream Bio during the 4th quarter valued at approximately $275,000. Bank of New York Mellon Corp purchased a new position in shares of Upstream Bio in the fourth quarter worth $607,000. Finally, JPMorgan Chase & Co. purchased a new position in shares of Upstream Bio in the fourth quarter worth $786,000.

Upstream Bio Stock Performance

Shares of UPB opened at $6.36 on Tuesday. The firm’s fifty day moving average is $8.11. Upstream Bio, Inc. has a 1-year low of $5.52 and a 1-year high of $29.46.

Upstream Bio Profile

Upstream Bio, Inc, a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease.